These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19132861)

  • 41. A QM/MM investigation of the catalytic mechanism of metal-ion-independent core 2 β1,6-N-acetylglucosaminyltransferase.
    Tvaroška I; Kozmon S; Wimmerová M; Koča J
    Chemistry; 2013 Jun; 19(25):8153-62. PubMed ID: 23616464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity.
    Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW
    J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.
    Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA
    Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shape complementarity, binding-site dynamics, and transition state stabilization: a theoretical study of Diels-Alder catalysis by antibody 1E9.
    Chen J; Deng Q; Wang R; Houk K; Hilvert D
    Chembiochem; 2000 Nov; 1(4):255-61. PubMed ID: 11828417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.
    Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA
    Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular dynamics simulations of the catalytic pathway of a cysteine protease: a combined QM/MM study of human cathepsin K.
    Ma S; Devi-Kesavan LS; Gao J
    J Am Chem Soc; 2007 Nov; 129(44):13633-45. PubMed ID: 17935329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple mutated antibody scFv2F3 with high GPx activity: insights from MD, docking, MDFE, and MM-PBSA simulation.
    Luo Q; Zhang C; Miao L; Zhang D; Bai Y; Hou C; Liu J; Yan F; Mu Y; Luo G
    Amino Acids; 2013 Mar; 44(3):1009-19. PubMed ID: 23224825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential of mean force calculation for the proton and hydride transfer reactions catalyzed by medium-chain acyl-CoA dehydrogenase: effect of mutations on enzyme catalysis.
    Bhattacharyya S; Ma S; Stankovich MT; Truhlar DG; Gao J
    Biochemistry; 2005 Dec; 44(50):16549-62. PubMed ID: 16342946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyridoxal-5'-phosphate-dependent catalytic antibodies.
    Gramatikova S; Mouratou B; Stetefeld J; Mehta PK; Christen P
    J Immunol Methods; 2002 Nov; 269(1-2):99-110. PubMed ID: 12379355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tech.Sight. Antibody design by man and nature.
    Wentworth P
    Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody catalysis of pericyclic reactions.
    Ulrich HD; Driggers EM; Schultz PG
    Acta Chem Scand (Cph); 1996 Apr; 50(4):328-32. PubMed ID: 8639375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.